Healthcare & Life Sciences

USPTO Trademark Application for VCLCLCXX

The USPTO has received an intent-to-use trademark application for the mark VCLCLCXX. The application lists goods including ear picks, ear plugs for various uses, and massage gloves. The filing date for this application was March 24, 2026.

USPTO Trademark Application for CANTSY Reading Glasses

The USPTO has received an intent-to-use trademark application for the mark "CANTSY" for reading glasses. The application was filed on March 24, 2026, with an intended effective date of March 25, 2026.

Recovery in Motion Trademark Application - Cryotherapy Machines

The USPTO has received an intent-to-use trademark application for 'Recovery in Motion' for cryotherapy machines used for medical purposes and therapeutic treatment after surgery. The application was filed on August 18, 2025, with an intended use date of March 24, 2026.

USPTO Trademark Application - K-Flex Ankle for Prosthetic Feet

The USPTO has received an intent-to-use trademark application for 'K-FLEX ANKLE' for prosthetic feet. The application was filed on August 15, 2025, and is designated for Class 010, which covers medical devices.

USPTO Trademark Application for Prosthetic Limbs

The USPTO has received an intent-to-use trademark application for prosthetic limbs, feet, and legs. The application was filed on August 15, 2025, and is designated for use with medical devices.

Vēro One Trademark Application for Medical Containers

The USPTO has received an intent-to-use trademark application for the mark 'Vēro One'. The application covers a range of temperature-controlled containers and packaging for medical and pharmaceutical products, including medicines, organs, and diagnostic materials. The filing date for this application was August 15, 2025.

QUADLOCK Trademark Filing for Medical Instruments

The USPTO has received an intent-to-use trademark application for the mark QUADLOCK, filed by an unnamed applicant. The application covers medical instruments and apparatus for orthopedic surgery, including implants, sutures, and fixation devices.

USPTO Trademark Application for SKINLOVINIT - Medical Devices

The USPTO has received an intent-to-use trademark application for the mark SKINLOVINIT. The application covers various medical devices, including therapeutic packs, electronic aesthetic skin treatment devices, microneedle rollers, and lasers for cosmetic treatment.

USPTO Trademark Application Filed for Heat Pack Therapy Apparatus

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for 'Heat pack therapy apparatus for pain relief'. The application was filed on August 14, 2025, with an intended use date of March 24, 2026.

USPTO Trademark Application: KALOVERA for Lasers

The USPTO has received an intent-to-use trademark application for the mark "KALOVERA" filed on August 14, 2025. The application covers lasers intended for medical use and cosmetic treatment of the face and skin.

USPTO Trademark Application: KALOLIGHT for Lasers

The USPTO has received an intent-to-use trademark application for the mark 'KALOLIGHT'. The application covers lasers for medical and cosmetic use, including devices for aesthetic skin treatments. The filing date for this application was August 14, 2025.

LUMENIXA Trademark Application for Medical Aesthetic Devices

The USPTO has received an intent-to-use trademark application for the mark LUMENIXA. The application covers electronic aesthetic skin treatment devices, thermotherapy apparatus, and massaging apparatus for personal and medical use.

USPTO Trademark Application for UNIO Medical Syringes

The USPTO has received an intent-to-use trademark application for the mark 'UNIO' in connection with medical syringes. The application was filed on August 14, 2025, with an intended use date of March 24, 2026.

USPTO Trademark Application for MAHP Ear Muffs

The USPTO has received an intent-to-use trademark application for the mark 'MAHP' for ear muffs and ear buds intended for hearing protection. The application was filed on August 13, 2025, with an expected effective date of March 24, 2026.

DEA: SpecGx LLC Bulk Manufacturer Controlled Substances Application Notice

The Drug Enforcement Administration (DEA) has issued a notice regarding an application from SpecGx LLC, a bulk manufacturer, to be registered for the production of various controlled substances. The notice provides a list of controlled substances and their schedules for which the company is seeking registration.

Lamotrigine Salts, Co-crystals, and Compositions Patent Application

The USPTO has published a patent application (US20260083745A1) for lamotrigine oral suspension and its preparation method, filed by Azurity Pharmaceuticals Ireland Limited. The application details a formulation designed to improve the stability and redispersibility of lamotrigine suspensions.

Patent Application: 7-Cyano-8-Hydroxyquinoline Derivative Medical Use

The USPTO has published a patent application for a 7-cyano-8-hydroxyquinoline derivative, its preparation method, and its medical use in treating infectious diseases or cancer. The application details a compound with potential antibacterial, antiviral, and antitumor activity.

Wrexham Adult Social Care Services Assurance Check

The Care Inspectorate Wales (CIW) will conduct an assurance check of Wrexham County Borough Council's adult social care services during April 2026. The check aims to review the council's performance in fulfilling its social services duties. Feedback from service users is requested via surveys by April 20, 2026.

Anglesey Council Children Services Assurance Check Findings

Care Inspectorate Wales has concluded an assurance check of Isle of Anglesey County Council's children's services. The check, conducted in January 2026, identified strengths in safeguarding and partnership working, alongside areas for improvement related to recording standards and workforce capacity due to rising demand.

Childcare and Play Practice Report for Wales

The Care Inspectorate Wales has published a new report highlighting excellent practices in childcare and play settings across Wales. The report identifies common themes in effective practice, such as supporting emotional wellbeing, embracing inclusivity, and using outdoor environments, aiming to help sector professionals improve their services.

Wales CIW: Deadline for SASS 2026 Submission

The Care Inspectorate Wales (CIW) has issued a notice reminding registered childminders and childcare providers that the deadline to complete their Self-Assessment of Service Statement (SASS) 2026 is March 27, 2026. Failure to submit the SASS, a legal requirement, may impact future service ratings.

Annual Report on Deprivation of Liberty Safeguards in Wales 2024-2025

Healthcare Inspectorate Wales and Care Inspectorate Wales have published their annual report on Deprivation of Liberty Safeguards (DoLS) in Wales for 2024-2025. The report indicates an increase in DoLS applications and assessments but highlights persistent challenges with delays and inconsistent application of safeguards, potentially leaving vulnerable individuals unprotected.

RQIA Guidance on Dental Care Abroad

The RQIA has issued guidance for individuals considering travelling abroad for dental treatment. The document outlines potential risks, emphasizes the importance of researching foreign dental regulations and professional registration, and advises consulting with a UK dentist before proceeding.

Safeguarding Children and Young People in Northern Ireland Policy

The RQIA has issued guidance on co-operating to safeguard children and young people in Northern Ireland. This policy outlines the legislative context, principles, and responsibilities of various bodies, including Health and Social Care, Justice, and Education sectors, in protecting children.

RQIA Medicines Management Audit Tool for Care Homes

The RQIA (Northern Ireland) has released a Medicines Management Audit Tool template for care homes. Developed in collaboration with care homes, this tool aims to assist managers and providers in developing their own audit processes for medication management.

Medicines Management Audit Tool for Children's Homes

The RQIA has released an audit tool to assist managers and providers of children's homes in monitoring the management of medicines. The tool covers areas such as training, competency, governance, and incident reporting, and references the Minimum Standards for Children's Homes.

Nursing Home Guidance on Medicine Disposal and Record Keeping

The Regulation and Quality Improvement Authority (RQIA) has issued guidance for nursing homes in Northern Ireland on the proper disposal of medicines, including controlled drugs. This guidance clarifies legislative requirements under the Controlled Waste Regulations (Northern Ireland) 2002 and the Waste Management Licensing Regulations (Northern Ireland) 2003, effective December 1, 2011.

North Carolina Child Abuse Prevention Month Event

The North Carolina Department of Health and Human Services and Positive Childhood Alliance NC are hosting a free community event on April 1, 2026, to recognize Child Abuse Prevention Month. Governor Josh Stein has proclaimed April as Child Abuse Prevention Month in North Carolina, with the campaign theme 'Positive Childhoods Start With Us.'

TANF and MOE Annual Report Submission for OMB Review

The Administration for Children and Families (ACF) is requesting a 3-year extension for the Annual TANF and MOE Report (OMB #0970-0248). While no substantive changes are made to the form itself, the instructions have been updated, and burden estimates adjusted. This action supports GAO recommendations for enhanced oversight of TANF funds.

CMS Seeks Public Comment on Information Collection Activities

The Centers for Medicare & Medicaid Services (CMS) has published a notice requesting public comment on its intention to collect information from the public. This action is part of the process under the Paperwork Reduction Act of 1995, requiring agency submissions for review and approval by the Office of Management and Budget (OMB).

CMS Launches ASPIRE Model for Medicaid Children's Care

The Centers for Medicare & Medicaid Services (CMS) has launched the ASPIRE model to improve care coordination for Medicaid children and families. The AMA welcomed the initiative, which aims to connect physicians with broader networks and support better management of chronic conditions for vulnerable populations.

Iowa Board of Pharmacy Newsletter October 2025

The Iowa Board of Pharmacy newsletter for October 2025 announces new board members and updates on expanded authority for statewide protocol development. It also details changes to business license application processes allowing retention of existing license numbers and notes that Long-Term Care Facilities and Assisted Living Facilities no longer require CSA registration.

Iowa Board of Pharmacy Adopts UMPJE Exam, Updates PMP Access

The Iowa Board of Pharmacy announced the adoption of the Uniform Multistate Pharmacy Jurisprudence Exam (UMPJE) effective April 1, 2026, and updated access policies for its Prescription Management Program (PMP). Pharmacist access to the Rx Management tool is now restricted to those with a DEA registration number, and data submissions missing a prescriber's DEA number will be flagged as errors.

Iowa Board of Pharmacy Newsletter: Rule Review and PMP Changes

The April 2025 Pharma Phacts newsletter from the Iowa Board of Pharmacy details ongoing administrative rule reviews mandated by Executive Order 10. Two chapters have been republished under Amended Notices of Intended Action following public comment, with a comment period closing March 25, 2025. The newsletter also notes the Board of Pharmacy rules are moving to Agency ID 481 under the Department of Inspections, Appeals, and Licensing (DIAL).

Iowa Board of Pharmacy Newsletter: Rule Delays, MPJE Update, New Board Members

The Iowa Board of Pharmacy announced a 70-day administrative delay for adopted rules that would have rescinded and created new chapters in the Iowa Administrative Code. Despite this delay, the Multistate Pharmacy Jurisprudence Examination (MPJE) content will reflect the new rules effective August 1, 2025, to prepare new graduates and out-of-state pharmacists for eventual implementation.

KS Boards of Pharmacy and Healing Arts Joint Statement on IV Therapy Clinics

The Kansas Boards of Pharmacy and Healing Arts have issued a joint statement addressing concerns about patient safety and regulatory compliance in retail IV therapy clinics. The statement clarifies that IV therapy is a medical practice requiring licensed professionals and outlines the Boards' investigative and referral processes for complaints.

KS Board of Pharmacy: Proposed Regulation Changes and Updates

The Kansas Board of Pharmacy is proposing changes to administrative regulations, including K.A.R. 68-5-17 and 68-7-26, and revoking K.A.R. 68-1-1a. The newsletter also reminds pharmacists and technicians about free CE on PMP data integrity and requests feedback on USP <797> and <795> adoption.

Kansas Pharmacy Technician Renewal Deadline and Requirements

The Kansas Board of Pharmacy has issued a newsletter reminding pharmacy technicians of the October 31, 2025 renewal deadline. Technicians must complete 20 hours of continuing education and can request a six-month extension if they cannot pass the certification exam by the deadline. Failure to renew will result in registration cancellation and requires a new application process.

Kansas Board of Pharmacy Named 2025 Wellbeing First Champion

The Kansas Board of Pharmacy has been recognized as a 2025 Wellbeing First Champion for removing stigmatizing language from its licensing and renewal applications related to mental health. The Board is also initiating a stakeholder process to solicit feedback on its rules and regulations, with submissions due by October 31, 2025.

Kansas Adopts Uniform MPJE for Pharmacist Licensure

The Kansas Board of Pharmacy has adopted the Uniform Multistate Pharmacy Jurisprudence Examination (MPJE) for pharmacist licensure, effective April 1, 2026. New graduates and pharmacists transferring licenses will be required to pass the Uniform MPJE, with the previous Kansas MPJE being discontinued at the end of 2026.

National Eye Institute Announces Closed Meeting Notice

The National Institutes of Health has issued a notice announcing a closed meeting of the Board of Scientific Counselors, National Eye Institute. The meeting will be held virtually on April 6, 2026, to review and evaluate individual intramural programs, personnel qualifications, and investigator performance.

FDA Correction: Withdrawal of 72 ANDAs - Upsher-Smith Laboratories

The FDA issued a correction to a notice that incorrectly announced the withdrawal of approval for Upsher-Smith Laboratories' abbreviated new drug application (ANDA) 070631 for valproic acid capsules. The company had timely requested that the approval not be withdrawn, and this correction reinstates its validity.

FDA Complaint Filed and Closed for Comments

The FDA has filed a complaint related to tobacco products, with the comment period now closed. The specific details of the complaint and the affected parties are not available in the provided document.

FDA Variance Renewal Request from Shine On Floyd Band

The Food and Drug Administration (FDA) has received a variance renewal request from Shine On Floyd Band. The document is available for review on regulations.gov, though no specific details or content are provided within the listing itself.

FDA Complaint Document

The FDA has posted a complaint document related to FDA-2026-H-2608. The document is available for review, though no specific details about its content are provided in the initial posting. This notice serves to inform the public and relevant parties of the complaint's availability.

FDA Completeness Assessment Correspondence

The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice provides information from the Center for Drug Evaluation and Research (CDER) regarding the completeness of submitted applications.

Letter from U.S. Patent Office to FDA CDER

The FDA's Center for Drug Evaluation and Research (CDER) has posted a letter received from the U.S. Patent and Trademark Office. The document is dated March 25, 2026, and is available for review on Regulations.gov.

FDA Complaint Filed

The Food and Drug Administration (FDA) has filed a complaint related to tobacco products. The comment period for this filing has closed. No further details on the nature of the complaint or specific parties involved are available in the provided information.

FDA Complaint Posted

The FDA has posted a complaint on March 25, 2026, which was closed for comments. The complaint document is available for download from the agency's regulations.gov portal.

FDA Complaint Posted

The FDA has posted a complaint related to its regulations, with the comment period closing on March 25, 2026. The document is available for review on Regs.gov.